接受慢性羟氯喹治疗的患者中的 COVID-19 肺炎：三例 COVID-19 肺炎病例
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia.
作者信息
Rahman Awan K, Purdy Adam G, Ender Peter T
机构信息
Section of Pulmonary and Critical Care, St. Luke's University Health Network, Bethlehem, PA, USA.
Section of Infectious Diseases, St. Luke's University Health Network, Bethlehem, PA, USA.
出版信息
Case Rep Infect Dis. 2020 Oct 22;2020:8822753. doi: 10.1155/2020/8822753. eCollection 2020.
Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia.
由于羟氯喹对新冠病毒的体外活性，它作为新冠病毒肺炎的潜在预防和治疗药物受到了关注。这三例不同严重程度的新冠病毒肺炎发生在长期使用羟氯喹的情况下。这些病例表明不支持将羟氯喹作为新冠病毒肺炎的预防或治疗选择。
Zotero 插件